P3 Health Partners Inc. (NASDAQ: PIII) Stock Competitors & Peer Comparison
See PIII's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Care Facilities Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for PIII and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| PIII | $8.96 | -1.86% | 30.6M | -0.28 | -$33.00 | N/A |
| HCA | $402.39 | -1.66% | 87.7B | 13.98 | $28.96 | +0.74% |
| THC | $261.04 | -0.93% | 21.3B | 15.37 | $17.24 | N/A |
| FMS | $22.51 | +0.16% | 12.2B | 8.52 | $2.66 | +3.81% |
| EHC | $121.44 | -0.94% | 12.1B | 20.85 | $5.84 | +0.62% |
| DVA | $181.96 | +0.17% | 11.8B | 14.37 | $12.80 | N/A |
| UHS | $171.98 | +1.64% | 10.3B | 7.53 | $22.54 | +0.47% |
| ENSG | $171.92 | -0.10% | 10B | 24.75 | $6.90 | +0.15% |
| OSH | $39.00 | +0.08% | 9.5B | -17.65 | -$2.21 | N/A |
| CHE | $522.25 | -0.42% | 6.8B | 24.06 | $21.61 | +0.48% |
Stock Comparison
HCA Healthcare, Inc. (NYSE: HCA)
PIII vs HCA Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIII stands at 30.6M. In comparison, HCA has a market cap of 87.7B. Regarding current trading prices, PIII is priced at $8.96 on the NASDAQ, while HCA trades at $402.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIII currently has a P/E ratio of -0.28, whereas HCA's P/E ratio is 13.98. In terms of profitability, PIII's ROE is +1.61%, compared to HCA's ROE of -1.13%. Regarding short-term risk, PIII is less volatile compared to HCA. This indicates lower risk in terms of short-term price fluctuations for PIII.Check HCA's competition here
Tenet Healthcare Corporation (NYSE: THC)
PIII vs THC Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIII stands at 30.6M. In comparison, THC has a market cap of 21.3B. Regarding current trading prices, PIII is priced at $8.96 on the NASDAQ, while THC trades at $261.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIII currently has a P/E ratio of -0.28, whereas THC's P/E ratio is 15.37. In terms of profitability, PIII's ROE is +1.61%, compared to THC's ROE of +0.51%. Regarding short-term risk, PIII is more volatile compared to THC. This indicates higher risk in terms of short-term price fluctuations for PIII.Check THC's competition here
Fresenius Medical Care AG & Co. KGaA (NYSE: FMS)
PIII vs FMS Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIII stands at 30.6M. In comparison, FMS has a market cap of 12.2B. Regarding current trading prices, PIII is priced at $8.96 on the NASDAQ, while FMS trades at $22.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIII currently has a P/E ratio of -0.28, whereas FMS's P/E ratio is 8.52. In terms of profitability, PIII's ROE is +1.61%, compared to FMS's ROE of +0.07%. Regarding short-term risk, PIII is more volatile compared to FMS. This indicates higher risk in terms of short-term price fluctuations for PIII.Check FMS's competition here
Encompass Health Corporation (NYSE: EHC)
PIII vs EHC Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIII stands at 30.6M. In comparison, EHC has a market cap of 12.1B. Regarding current trading prices, PIII is priced at $8.96 on the NASDAQ, while EHC trades at $121.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIII currently has a P/E ratio of -0.28, whereas EHC's P/E ratio is 20.85. In terms of profitability, PIII's ROE is +1.61%, compared to EHC's ROE of +0.25%. Regarding short-term risk, PIII is more volatile compared to EHC. This indicates higher risk in terms of short-term price fluctuations for PIII.Check EHC's competition here
DaVita Inc. (NYSE: DVA)
PIII vs DVA Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIII stands at 30.6M. In comparison, DVA has a market cap of 11.8B. Regarding current trading prices, PIII is priced at $8.96 on the NASDAQ, while DVA trades at $181.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIII currently has a P/E ratio of -0.28, whereas DVA's P/E ratio is 14.37. In terms of profitability, PIII's ROE is +1.61%, compared to DVA's ROE of -1.24%. Regarding short-term risk, PIII is more volatile compared to DVA. This indicates higher risk in terms of short-term price fluctuations for PIII.Check DVA's competition here
Universal Health Services, Inc. (NYSE: UHS)
PIII vs UHS Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIII stands at 30.6M. In comparison, UHS has a market cap of 10.3B. Regarding current trading prices, PIII is priced at $8.96 on the NASDAQ, while UHS trades at $171.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIII currently has a P/E ratio of -0.28, whereas UHS's P/E ratio is 7.53. In terms of profitability, PIII's ROE is +1.61%, compared to UHS's ROE of +0.21%. Regarding short-term risk, PIII is more volatile compared to UHS. This indicates higher risk in terms of short-term price fluctuations for PIII.Check UHS's competition here
The Ensign Group, Inc. (NASDAQ: ENSG)
PIII vs ENSG Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIII stands at 30.6M. In comparison, ENSG has a market cap of 10B. Regarding current trading prices, PIII is priced at $8.96 on the NASDAQ, while ENSG trades at $171.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIII currently has a P/E ratio of -0.28, whereas ENSG's P/E ratio is 24.75. In terms of profitability, PIII's ROE is +1.61%, compared to ENSG's ROE of +0.17%. Regarding short-term risk, PIII is more volatile compared to ENSG. This indicates higher risk in terms of short-term price fluctuations for PIII.Check ENSG's competition here
Oak Street Health, Inc. (NYSE: OSH)
PIII vs OSH Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIII stands at 30.6M. In comparison, OSH has a market cap of 9.5B. Regarding current trading prices, PIII is priced at $8.96 on the NASDAQ, while OSH trades at $39.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIII currently has a P/E ratio of -0.28, whereas OSH's P/E ratio is -17.65. In terms of profitability, PIII's ROE is +1.61%, compared to OSH's ROE of +4.64%. Regarding short-term risk, PIII is more volatile compared to OSH. This indicates higher risk in terms of short-term price fluctuations for PIII.Check OSH's competition here
Chemed Corporation (NYSE: CHE)
PIII vs CHE Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIII stands at 30.6M. In comparison, CHE has a market cap of 6.8B. Regarding current trading prices, PIII is priced at $8.96 on the NASDAQ, while CHE trades at $522.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIII currently has a P/E ratio of -0.28, whereas CHE's P/E ratio is 24.06. In terms of profitability, PIII's ROE is +1.61%, compared to CHE's ROE of +0.29%. Regarding short-term risk, PIII is more volatile compared to CHE. This indicates higher risk in terms of short-term price fluctuations for PIII.Check CHE's competition here
PACS Group, Inc. (NYSE: PACS)
PIII vs PACS Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIII stands at 30.6M. In comparison, PACS has a market cap of 6.7B. Regarding current trading prices, PIII is priced at $8.96 on the NASDAQ, while PACS trades at $43.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIII currently has a P/E ratio of -0.28, whereas PACS's P/E ratio is 22.49. In terms of profitability, PIII's ROE is +1.61%, compared to PACS's ROE of +0.27%. Regarding short-term risk, PIII is less volatile compared to PACS. This indicates lower risk in terms of short-term price fluctuations for PIII.Check PACS's competition here
Hims & Hers Health, Inc. (NYSE: HIMS)
PIII vs HIMS Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIII stands at 30.6M. In comparison, HIMS has a market cap of 6.2B. Regarding current trading prices, PIII is priced at $8.96 on the NASDAQ, while HIMS trades at $27.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIII currently has a P/E ratio of -0.28, whereas HIMS's P/E ratio is -43.30. In terms of profitability, PIII's ROE is +1.61%, compared to HIMS's ROE of -0.30%. Regarding short-term risk, PIII is more volatile compared to HIMS. This indicates higher risk in terms of short-term price fluctuations for PIII.Check HIMS's competition here
LHC Group, Inc. (NASDAQ: LHCG)
PIII vs LHCG Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIII stands at 30.6M. In comparison, LHCG has a market cap of 5.3B. Regarding current trading prices, PIII is priced at $8.96 on the NASDAQ, while LHCG trades at $169.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIII currently has a P/E ratio of -0.28, whereas LHCG's P/E ratio is 82.83. In terms of profitability, PIII's ROE is +1.61%, compared to LHCG's ROE of +0.04%. Regarding short-term risk, PIII is more volatile compared to LHCG. This indicates higher risk in terms of short-term price fluctuations for PIII.Check LHCG's competition here
LifeStance Health Group, Inc. (NASDAQ: LFST)
PIII vs LFST Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIII stands at 30.6M. In comparison, LFST has a market cap of 4.9B. Regarding current trading prices, PIII is priced at $8.96 on the NASDAQ, while LFST trades at $12.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIII currently has a P/E ratio of -0.28, whereas LFST's P/E ratio is 95.88. In terms of profitability, PIII's ROE is +1.61%, compared to LFST's ROE of +0.03%. Regarding short-term risk, PIII is similarly volatile compared to LFST. This indicates similar risk in terms of short-term price fluctuations for PIII.Check LFST's competition here
Concentra Group Holdings Parent, Inc. (NYSE: CON)
PIII vs CON Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIII stands at 30.6M. In comparison, CON has a market cap of 4.4B. Regarding current trading prices, PIII is priced at $8.96 on the NASDAQ, while CON trades at $34.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIII currently has a P/E ratio of -0.28, whereas CON's P/E ratio is 21.68. In terms of profitability, PIII's ROE is +1.61%, compared to CON's ROE of +0.47%. Regarding short-term risk, PIII is more volatile compared to CON. This indicates higher risk in terms of short-term price fluctuations for PIII.Check CON's competition here
Option Care Health, Inc. (NASDAQ: OPCH)
PIII vs OPCH Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIII stands at 30.6M. In comparison, OPCH has a market cap of 3.6B. Regarding current trading prices, PIII is priced at $8.96 on the NASDAQ, while OPCH trades at $23.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIII currently has a P/E ratio of -0.28, whereas OPCH's P/E ratio is 14.08. In terms of profitability, PIII's ROE is +1.61%, compared to OPCH's ROE of +0.16%. Regarding short-term risk, PIII is more volatile compared to OPCH. This indicates higher risk in terms of short-term price fluctuations for PIII.Check OPCH's competition here
National HealthCare Corporation (AMEX: NHC)
PIII vs NHC Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIII stands at 30.6M. In comparison, NHC has a market cap of 3.4B. Regarding current trading prices, PIII is priced at $8.96 on the NASDAQ, while NHC trades at $222.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIII currently has a P/E ratio of -0.28, whereas NHC's P/E ratio is 27.82. In terms of profitability, PIII's ROE is +1.61%, compared to NHC's ROE of +0.13%. Regarding short-term risk, PIII is more volatile compared to NHC. This indicates higher risk in terms of short-term price fluctuations for PIII.Check NHC's competition here
Amedisys, Inc. (NASDAQ: AMED)
PIII vs AMED Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIII stands at 30.6M. In comparison, AMED has a market cap of 3.3B. Regarding current trading prices, PIII is priced at $8.96 on the NASDAQ, while AMED trades at $100.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIII currently has a P/E ratio of -0.28, whereas AMED's P/E ratio is 39.30. In terms of profitability, PIII's ROE is +1.61%, compared to AMED's ROE of +0.11%. Regarding short-term risk, PIII is more volatile compared to AMED. This indicates higher risk in terms of short-term price fluctuations for PIII.Check AMED's competition here
Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH)
PIII vs AVAH Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIII stands at 30.6M. In comparison, AVAH has a market cap of 3B. Regarding current trading prices, PIII is priced at $8.96 on the NASDAQ, while AVAH trades at $13.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIII currently has a P/E ratio of -0.28, whereas AVAH's P/E ratio is 19.97. In terms of profitability, PIII's ROE is +1.61%, compared to AVAH's ROE of +1.50%. Regarding short-term risk, PIII is less volatile compared to AVAH. This indicates lower risk in terms of short-term price fluctuations for PIII.Check AVAH's competition here
Brookdale Senior Living Inc. (NYSE: BKD)
PIII vs BKD Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIII stands at 30.6M. In comparison, BKD has a market cap of 2.8B. Regarding current trading prices, PIII is priced at $8.96 on the NASDAQ, while BKD trades at $12.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIII currently has a P/E ratio of -0.28, whereas BKD's P/E ratio is -20.29. In terms of profitability, PIII's ROE is +1.61%, compared to BKD's ROE of +4.06%. Regarding short-term risk, PIII is less volatile compared to BKD. This indicates lower risk in terms of short-term price fluctuations for PIII.Check BKD's competition here
Acadia Healthcare Company, Inc. (NASDAQ: ACHC)
PIII vs ACHC Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIII stands at 30.6M. In comparison, ACHC has a market cap of 2.6B. Regarding current trading prices, PIII is priced at $8.96 on the NASDAQ, while ACHC trades at $27.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIII currently has a P/E ratio of -0.28, whereas ACHC's P/E ratio is 14.14. In terms of profitability, PIII's ROE is +1.61%, compared to ACHC's ROE of -0.50%. Regarding short-term risk, PIII is less volatile compared to ACHC. This indicates lower risk in terms of short-term price fluctuations for PIII.Check ACHC's competition here
Guardian Pharmacy Services, Inc. (NYSE: GRDN)
PIII vs GRDN Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIII stands at 30.6M. In comparison, GRDN has a market cap of 2.6B. Regarding current trading prices, PIII is priced at $8.96 on the NASDAQ, while GRDN trades at $42.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIII currently has a P/E ratio of -0.28, whereas GRDN's P/E ratio is 35.76. In terms of profitability, PIII's ROE is +1.61%, compared to GRDN's ROE of +0.31%. Regarding short-term risk, PIII is less volatile compared to GRDN. This indicates lower risk in terms of short-term price fluctuations for PIII.Check GRDN's competition here
Pediatrix Medical Group, Inc. (NYSE: MD)
PIII vs MD Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIII stands at 30.6M. In comparison, MD has a market cap of 2.2B. Regarding current trading prices, PIII is priced at $8.96 on the NASDAQ, while MD trades at $26.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIII currently has a P/E ratio of -0.28, whereas MD's P/E ratio is 12.07. In terms of profitability, PIII's ROE is +1.61%, compared to MD's ROE of +0.20%. Regarding short-term risk, PIII is more volatile compared to MD. This indicates higher risk in terms of short-term price fluctuations for PIII.Check MD's competition here
Addus HomeCare Corporation (NASDAQ: ADUS)
PIII vs ADUS Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIII stands at 30.6M. In comparison, ADUS has a market cap of 2.2B. Regarding current trading prices, PIII is priced at $8.96 on the NASDAQ, while ADUS trades at $119.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIII currently has a P/E ratio of -0.28, whereas ADUS's P/E ratio is 17.78. In terms of profitability, PIII's ROE is +1.61%, compared to ADUS's ROE of +0.10%. Regarding short-term risk, PIII is more volatile compared to ADUS. This indicates higher risk in terms of short-term price fluctuations for PIII.Check ADUS's competition here
Select Medical Holdings Corporation (NYSE: SEM)
PIII vs SEM Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIII stands at 30.6M. In comparison, SEM has a market cap of 2B. Regarding current trading prices, PIII is priced at $8.96 on the NASDAQ, while SEM trades at $16.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIII currently has a P/E ratio of -0.28, whereas SEM's P/E ratio is 15.43. In terms of profitability, PIII's ROE is +1.61%, compared to SEM's ROE of +0.08%. Regarding short-term risk, PIII is more volatile compared to SEM. This indicates higher risk in terms of short-term price fluctuations for PIII.Check SEM's competition here
Astrana Health, Inc. (NASDAQ: ASTH)
PIII vs ASTH Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIII stands at 30.6M. In comparison, ASTH has a market cap of 1.9B. Regarding current trading prices, PIII is priced at $8.96 on the NASDAQ, while ASTH trades at $38.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIII currently has a P/E ratio of -0.28, whereas ASTH's P/E ratio is 46.35. In terms of profitability, PIII's ROE is +1.61%, compared to ASTH's ROE of +0.05%. Regarding short-term risk, PIII is more volatile compared to ASTH. This indicates higher risk in terms of short-term price fluctuations for PIII.Check ASTH's competition here
Surgery Partners, Inc. (NASDAQ: SGRY)
PIII vs SGRY Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIII stands at 30.6M. In comparison, SGRY has a market cap of 1.9B. Regarding current trading prices, PIII is priced at $8.96 on the NASDAQ, while SGRY trades at $14.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIII currently has a P/E ratio of -0.28, whereas SGRY's P/E ratio is 36.56. In terms of profitability, PIII's ROE is +1.61%, compared to SGRY's ROE of -0.05%. Regarding short-term risk, PIII is less volatile compared to SGRY. This indicates lower risk in terms of short-term price fluctuations for PIII.Check SGRY's competition here
Apollo Medical Holdings, Inc. (NASDAQ: AMEH)
PIII vs AMEH Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIII stands at 30.6M. In comparison, AMEH has a market cap of 1.8B. Regarding current trading prices, PIII is priced at $8.96 on the NASDAQ, while AMEH trades at $40.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIII currently has a P/E ratio of -0.28, whereas AMEH's P/E ratio is 39.25. In terms of profitability, PIII's ROE is +1.61%, compared to AMEH's ROE of +0.05%. Regarding short-term risk, PIII is less volatile compared to AMEH. This indicates lower risk in terms of short-term price fluctuations for PIII.Check AMEH's competition here
Sonida Senior Living, Inc. (NYSE: SNDA)
PIII vs SNDA Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIII stands at 30.6M. In comparison, SNDA has a market cap of 1.8B. Regarding current trading prices, PIII is priced at $8.96 on the NASDAQ, while SNDA trades at $39.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIII currently has a P/E ratio of -0.28, whereas SNDA's P/E ratio is -6.09. In terms of profitability, PIII's ROE is +1.61%, compared to SNDA's ROE of -0.26%. Regarding short-term risk, PIII is less volatile compared to SNDA. This indicates lower risk in terms of short-term price fluctuations for PIII.Check SNDA's competition here
Ardent Health Inc. (NYSE: ARDT)
PIII vs ARDT Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIII stands at 30.6M. In comparison, ARDT has a market cap of 1.6B. Regarding current trading prices, PIII is priced at $8.96 on the NASDAQ, while ARDT trades at $10.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIII currently has a P/E ratio of -0.28, whereas ARDT's P/E ratio is 8.80. In terms of profitability, PIII's ROE is +1.61%, compared to ARDT's ROE of +0.05%. Regarding short-term risk, PIII is more volatile compared to ARDT. This indicates higher risk in terms of short-term price fluctuations for PIII.Check ARDT's competition here
Healthcare Services Group, Inc. (NASDAQ: HCSG)
PIII vs HCSG Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIII stands at 30.6M. In comparison, HCSG has a market cap of 1.5B. Regarding current trading prices, PIII is priced at $8.96 on the NASDAQ, while HCSG trades at $21.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIII currently has a P/E ratio of -0.28, whereas HCSG's P/E ratio is 17.46. In terms of profitability, PIII's ROE is +1.61%, compared to HCSG's ROE of +0.24%. Regarding short-term risk, PIII is more volatile compared to HCSG. This indicates higher risk in terms of short-term price fluctuations for PIII.Check HCSG's competition here
Agilon Health, Inc. (NYSE: AGL)
PIII vs AGL Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIII stands at 30.6M. In comparison, AGL has a market cap of 1.5B. Regarding current trading prices, PIII is priced at $8.96 on the NASDAQ, while AGL trades at $91.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIII currently has a P/E ratio of -0.28, whereas AGL's P/E ratio is -5.74. In terms of profitability, PIII's ROE is +1.61%, compared to AGL's ROE of -1.19%. Regarding short-term risk, PIII is less volatile compared to AGL. This indicates lower risk in terms of short-term price fluctuations for PIII.Check AGL's competition here
Innovage Holding Corp. (NASDAQ: INNV)
PIII vs INNV Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIII stands at 30.6M. In comparison, INNV has a market cap of 1.5B. Regarding current trading prices, PIII is priced at $8.96 on the NASDAQ, while INNV trades at $10.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIII currently has a P/E ratio of -0.28, whereas INNV's P/E ratio is -119.44. In terms of profitability, PIII's ROE is +1.61%, compared to INNV's ROE of -0.09%. Regarding short-term risk, PIII is less volatile compared to INNV. This indicates lower risk in terms of short-term price fluctuations for PIII.Check INNV's competition here
Nutex Health, Inc. (NASDAQ: NUTX)
PIII vs NUTX Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIII stands at 30.6M. In comparison, NUTX has a market cap of 1.3B. Regarding current trading prices, PIII is priced at $8.96 on the NASDAQ, while NUTX trades at $192.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIII currently has a P/E ratio of -0.28, whereas NUTX's P/E ratio is 7.65. In terms of profitability, PIII's ROE is +1.61%, compared to NUTX's ROE of +0.52%. Regarding short-term risk, PIII is less volatile compared to NUTX. This indicates lower risk in terms of short-term price fluctuations for PIII.Check NUTX's competition here
The Pennant Group, Inc. (NASDAQ: PNTG)
PIII vs PNTG Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIII stands at 30.6M. In comparison, PNTG has a market cap of 1.3B. Regarding current trading prices, PIII is priced at $8.96 on the NASDAQ, while PNTG trades at $39.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIII currently has a P/E ratio of -0.28, whereas PNTG's P/E ratio is 28.79. In terms of profitability, PIII's ROE is +1.61%, compared to PNTG's ROE of +0.10%. Regarding short-term risk, PIII is less volatile compared to PNTG. This indicates lower risk in terms of short-term price fluctuations for PIII.Check PNTG's competition here
AMN Healthcare Services, Inc. (NYSE: AMN)
PIII vs AMN Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIII stands at 30.6M. In comparison, AMN has a market cap of 1.3B. Regarding current trading prices, PIII is priced at $8.96 on the NASDAQ, while AMN trades at $33.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIII currently has a P/E ratio of -0.28, whereas AMN's P/E ratio is 11.23. In terms of profitability, PIII's ROE is +1.61%, compared to AMN's ROE of +0.15%. Regarding short-term risk, PIII is less volatile compared to AMN. This indicates lower risk in terms of short-term price fluctuations for PIII.Check AMN's competition here
Brookdale Senior Living Inc. 7. (NYSE: BKDT)
PIII vs BKDT Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIII stands at 30.6M. In comparison, BKDT has a market cap of 1.2B. Regarding current trading prices, PIII is priced at $8.96 on the NASDAQ, while BKDT trades at $77.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIII currently has a P/E ratio of -0.28, whereas BKDT's P/E ratio is N/A. In terms of profitability, PIII's ROE is +1.61%, compared to BKDT's ROE of +4.06%. Regarding short-term risk, PIII is more volatile compared to BKDT. This indicates higher risk in terms of short-term price fluctuations for PIII.Check BKDT's competition here
U.S. Physical Therapy, Inc. (NYSE: USPH)
PIII vs USPH Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIII stands at 30.6M. In comparison, USPH has a market cap of 1.2B. Regarding current trading prices, PIII is priced at $8.96 on the NASDAQ, while USPH trades at $79.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIII currently has a P/E ratio of -0.28, whereas USPH's P/E ratio is 31.24. In terms of profitability, PIII's ROE is +1.61%, compared to USPH's ROE of -0.01%. Regarding short-term risk, PIII is more volatile compared to USPH. This indicates higher risk in terms of short-term price fluctuations for PIII.Check USPH's competition here
Talkspace, Inc. (NASDAQ: TALK)
PIII vs TALK Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIII stands at 30.6M. In comparison, TALK has a market cap of 879.4M. Regarding current trading prices, PIII is priced at $8.96 on the NASDAQ, while TALK trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIII currently has a P/E ratio of -0.28, whereas TALK's P/E ratio is 774.34. In terms of profitability, PIII's ROE is +1.61%, compared to TALK's ROE of +0.00%. Regarding short-term risk, PIII is more volatile compared to TALK. This indicates higher risk in terms of short-term price fluctuations for PIII.Check TALK's competition here
GMR Solutions Inc. (NYSE: GMRS)
PIII vs GMRS Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIII stands at 30.6M. In comparison, GMRS has a market cap of 727M. Regarding current trading prices, PIII is priced at $8.96 on the NASDAQ, while GMRS trades at $14.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIII currently has a P/E ratio of -0.28, whereas GMRS's P/E ratio is 5.98. In terms of profitability, PIII's ROE is +1.61%, compared to GMRS's ROE of +0.16%. Regarding short-term risk, PIII is less volatile compared to GMRS. This indicates lower risk in terms of short-term price fluctuations for PIII.Check GMRS's competition here
Enhabit, Inc. (NYSE: EHAB)
PIII vs EHAB Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIII stands at 30.6M. In comparison, EHAB has a market cap of 706.9M. Regarding current trading prices, PIII is priced at $8.96 on the NASDAQ, while EHAB trades at $13.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIII currently has a P/E ratio of -0.28, whereas EHAB's P/E ratio is -197.14. In terms of profitability, PIII's ROE is +1.61%, compared to EHAB's ROE of -0.01%. Regarding short-term risk, PIII is more volatile compared to EHAB. This indicates higher risk in terms of short-term price fluctuations for PIII.Check EHAB's competition here
Starling Oncology, Inc. (NASDAQ: STLN)
PIII vs STLN Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIII stands at 30.6M. In comparison, STLN has a market cap of 592.9M. Regarding current trading prices, PIII is priced at $8.96 on the NASDAQ, while STLN trades at $6.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIII currently has a P/E ratio of -0.28, whereas STLN's P/E ratio is N/A. In terms of profitability, PIII's ROE is +1.61%, compared to STLN's ROE of +2.10%. Regarding short-term risk, PIII is less volatile compared to STLN. This indicates lower risk in terms of short-term price fluctuations for PIII.Check STLN's competition here
The Oncology Institute, Inc. (NASDAQ: TOI)
PIII vs TOI Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIII stands at 30.6M. In comparison, TOI has a market cap of 512.9M. Regarding current trading prices, PIII is priced at $8.96 on the NASDAQ, while TOI trades at $5.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIII currently has a P/E ratio of -0.28, whereas TOI's P/E ratio is -14.25. In terms of profitability, PIII's ROE is +1.61%, compared to TOI's ROE of +2.10%. Regarding short-term risk, PIII is less volatile compared to TOI. This indicates lower risk in terms of short-term price fluctuations for PIII.Check TOI's competition here
Strata Critical Medical, Inc. (NASDAQ: SRTA)
PIII vs SRTA Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIII stands at 30.6M. In comparison, SRTA has a market cap of 460.3M. Regarding current trading prices, PIII is priced at $8.96 on the NASDAQ, while SRTA trades at $5.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIII currently has a P/E ratio of -0.28, whereas SRTA's P/E ratio is -25.08. In terms of profitability, PIII's ROE is +1.61%, compared to SRTA's ROE of +0.14%. Regarding short-term risk, PIII is more volatile compared to SRTA. This indicates higher risk in terms of short-term price fluctuations for PIII.Check SRTA's competition here
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA)
PIII vs MCTA Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIII stands at 30.6M. In comparison, MCTA has a market cap of 445.6M. Regarding current trading prices, PIII is priced at $8.96 on the NASDAQ, while MCTA trades at $29.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIII currently has a P/E ratio of -0.28, whereas MCTA's P/E ratio is 419.36. In terms of profitability, PIII's ROE is +1.61%, compared to MCTA's ROE of -2.33%. Regarding short-term risk, PIII is more volatile compared to MCTA. This indicates higher risk in terms of short-term price fluctuations for PIII.Check MCTA's competition here
Community Health Systems, Inc. (NYSE: CYH)
PIII vs CYH Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIII stands at 30.6M. In comparison, CYH has a market cap of 407.5M. Regarding current trading prices, PIII is priced at $8.96 on the NASDAQ, while CYH trades at $2.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIII currently has a P/E ratio of -0.28, whereas CYH's P/E ratio is 3.96. In terms of profitability, PIII's ROE is +1.61%, compared to CYH's ROE of +0.21%. Regarding short-term risk, PIII is more volatile compared to CYH. This indicates higher risk in terms of short-term price fluctuations for PIII.Check CYH's competition here
Auna S.A. (NYSE: AUNA)
PIII vs AUNA Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIII stands at 30.6M. In comparison, AUNA has a market cap of 390.8M. Regarding current trading prices, PIII is priced at $8.96 on the NASDAQ, while AUNA trades at $5.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIII currently has a P/E ratio of -0.28, whereas AUNA's P/E ratio is 4.76. In terms of profitability, PIII's ROE is +1.61%, compared to AUNA's ROE of +0.01%. Regarding short-term risk, PIII is more volatile compared to AUNA. This indicates higher risk in terms of short-term price fluctuations for PIII.Check AUNA's competition here
Viemed Healthcare, Inc. (NASDAQ: VMD)
PIII vs VMD Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIII stands at 30.6M. In comparison, VMD has a market cap of 345.8M. Regarding current trading prices, PIII is priced at $8.96 on the NASDAQ, while VMD trades at $8.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIII currently has a P/E ratio of -0.28, whereas VMD's P/E ratio is 25.22. In terms of profitability, PIII's ROE is +1.61%, compared to VMD's ROE of +0.10%. Regarding short-term risk, PIII is more volatile compared to VMD. This indicates higher risk in terms of short-term price fluctuations for PIII.Check VMD's competition here
Capital Senior Living Corporation (NYSE: CSU)
PIII vs CSU Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIII stands at 30.6M. In comparison, CSU has a market cap of 223.7M. Regarding current trading prices, PIII is priced at $8.96 on the NASDAQ, while CSU trades at $33.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIII currently has a P/E ratio of -0.28, whereas CSU's P/E ratio is 0.67. In terms of profitability, PIII's ROE is +1.61%, compared to CSU's ROE of -0.33%. Regarding short-term risk, PIII is less volatile compared to CSU. This indicates lower risk in terms of short-term price fluctuations for PIII.Check CSU's competition here
AirSculpt Technologies, Inc. (NASDAQ: AIRS)
PIII vs AIRS Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIII stands at 30.6M. In comparison, AIRS has a market cap of 197.2M. Regarding current trading prices, PIII is priced at $8.96 on the NASDAQ, while AIRS trades at $2.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIII currently has a P/E ratio of -0.28, whereas AIRS's P/E ratio is -93.17. In terms of profitability, PIII's ROE is +1.61%, compared to AIRS's ROE of -0.13%. Regarding short-term risk, PIII is less volatile compared to AIRS. This indicates lower risk in terms of short-term price fluctuations for PIII.Check AIRS's competition here
The Joint Corp. (NASDAQ: JYNT)
PIII vs JYNT Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIII stands at 30.6M. In comparison, JYNT has a market cap of 118.6M. Regarding current trading prices, PIII is priced at $8.96 on the NASDAQ, while JYNT trades at $8.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIII currently has a P/E ratio of -0.28, whereas JYNT's P/E ratio is 83.20. In terms of profitability, PIII's ROE is +1.61%, compared to JYNT's ROE of +0.22%. Regarding short-term risk, PIII is more volatile compared to JYNT. This indicates higher risk in terms of short-term price fluctuations for PIII.Check JYNT's competition here
Five Star Senior Living Inc. (NASDAQ: FVE)
PIII vs FVE Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIII stands at 30.6M. In comparison, FVE has a market cap of 98.4M. Regarding current trading prices, PIII is priced at $8.96 on the NASDAQ, while FVE trades at $2.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIII currently has a P/E ratio of -0.28, whereas FVE's P/E ratio is -5.64. In terms of profitability, PIII's ROE is +1.61%, compared to FVE's ROE of -0.15%. Regarding short-term risk, PIII is more volatile compared to FVE. This indicates higher risk in terms of short-term price fluctuations for PIII.Check FVE's competition here
Kindly MD, Inc. (NASDAQ: KDLYW)
PIII vs KDLYW Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIII stands at 30.6M. In comparison, KDLYW has a market cap of 96.5M. Regarding current trading prices, PIII is priced at $8.96 on the NASDAQ, while KDLYW trades at $18.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIII currently has a P/E ratio of -0.28, whereas KDLYW's P/E ratio is N/A. In terms of profitability, PIII's ROE is +1.61%, compared to KDLYW's ROE of -1.05%. Regarding short-term risk, PIII is less volatile compared to KDLYW. This indicates lower risk in terms of short-term price fluctuations for PIII.Check KDLYW's competition here
Park Dental Partners, Inc. Common Stock (NASDAQ: PARK)
PIII vs PARK Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIII stands at 30.6M. In comparison, PARK has a market cap of 92.2M. Regarding current trading prices, PIII is priced at $8.96 on the NASDAQ, while PARK trades at $20.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIII currently has a P/E ratio of -0.28, whereas PARK's P/E ratio is 27.61. In terms of profitability, PIII's ROE is +1.61%, compared to PARK's ROE of -0.18%. Regarding short-term risk, PIII is more volatile compared to PARK. This indicates higher risk in terms of short-term price fluctuations for PIII.Check PARK's competition here
biote Corp. (NASDAQ: BTMD)
PIII vs BTMD Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIII stands at 30.6M. In comparison, BTMD has a market cap of 68.1M. Regarding current trading prices, PIII is priced at $8.96 on the NASDAQ, while BTMD trades at $1.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIII currently has a P/E ratio of -0.28, whereas BTMD's P/E ratio is 14.05. In terms of profitability, PIII's ROE is +1.61%, compared to BTMD's ROE of -0.09%. Regarding short-term risk, PIII is less volatile compared to BTMD. This indicates lower risk in terms of short-term price fluctuations for PIII.Check BTMD's competition here
AlerisLife Inc. (NASDAQ: ALR)
PIII vs ALR Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIII stands at 30.6M. In comparison, ALR has a market cap of 44.2M. Regarding current trading prices, PIII is priced at $8.96 on the NASDAQ, while ALR trades at $1.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIII currently has a P/E ratio of -0.28, whereas ALR's P/E ratio is -1.11. In terms of profitability, PIII's ROE is +1.61%, compared to ALR's ROE of -0.15%. Regarding short-term risk, PIII is more volatile compared to ALR. This indicates higher risk in terms of short-term price fluctuations for PIII.Check ALR's competition here
DocGo Inc. (NASDAQ: DCGO)
PIII vs DCGO Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIII stands at 30.6M. In comparison, DCGO has a market cap of 39.8M. Regarding current trading prices, PIII is priced at $8.96 on the NASDAQ, while DCGO trades at $0.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIII currently has a P/E ratio of -0.28, whereas DCGO's P/E ratio is -0.22. In terms of profitability, PIII's ROE is +1.61%, compared to DCGO's ROE of -1.16%. Regarding short-term risk, PIII is less volatile compared to DCGO. This indicates lower risk in terms of short-term price fluctuations for PIII.Check DCGO's competition here
Cryo-Cell International, Inc. (AMEX: CCEL)
PIII vs CCEL Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIII stands at 30.6M. In comparison, CCEL has a market cap of 34.5M. Regarding current trading prices, PIII is priced at $8.96 on the NASDAQ, while CCEL trades at $4.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIII currently has a P/E ratio of -0.28, whereas CCEL's P/E ratio is -14.27. In terms of profitability, PIII's ROE is +1.61%, compared to CCEL's ROE of +0.14%. Regarding short-term risk, PIII is less volatile compared to CCEL. This indicates lower risk in terms of short-term price fluctuations for PIII.Check CCEL's competition here
IMAC Holdings, Inc. (NASDAQ: IMAC)
PIII vs IMAC Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIII stands at 30.6M. In comparison, IMAC has a market cap of 33.1M. Regarding current trading prices, PIII is priced at $8.96 on the NASDAQ, while IMAC trades at $1.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIII currently has a P/E ratio of -0.28, whereas IMAC's P/E ratio is -2.27. In terms of profitability, PIII's ROE is +1.61%, compared to IMAC's ROE of +0.00%. Regarding short-term risk, PIII is more volatile compared to IMAC. This indicates higher risk in terms of short-term price fluctuations for PIII.Check IMAC's competition here
EUDA Health Holdings Limited (NASDAQ: EUDA)
PIII vs EUDA Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIII stands at 30.6M. In comparison, EUDA has a market cap of 25.2M. Regarding current trading prices, PIII is priced at $8.96 on the NASDAQ, while EUDA trades at $13.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIII currently has a P/E ratio of -0.28, whereas EUDA's P/E ratio is -25.45. In terms of profitability, PIII's ROE is +1.61%, compared to EUDA's ROE of +1.20%. Regarding short-term risk, PIII is less volatile compared to EUDA. This indicates lower risk in terms of short-term price fluctuations for PIII.Check EUDA's competition here
P3 Health Partners Inc. (NASDAQ: PIIIW)
PIII vs PIIIW Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIII stands at 30.6M. In comparison, PIIIW has a market cap of 24.5M. Regarding current trading prices, PIII is priced at $8.96 on the NASDAQ, while PIIIW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIII currently has a P/E ratio of -0.28, whereas PIIIW's P/E ratio is N/A. In terms of profitability, PIII's ROE is +1.61%, compared to PIIIW's ROE of +1.61%. Regarding short-term risk, PIII is more volatile compared to PIIIW. This indicates higher risk in terms of short-term price fluctuations for PIII.Check PIIIW's competition here
Cano Health, Inc. (NYSE: CANO-WT)
PIII vs CANO-WT Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIII stands at 30.6M. In comparison, CANO-WT has a market cap of 19.3M. Regarding current trading prices, PIII is priced at $8.96 on the NASDAQ, while CANO-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIII currently has a P/E ratio of -0.28, whereas CANO-WT's P/E ratio is N/A. In terms of profitability, PIII's ROE is +1.61%, compared to CANO-WT's ROE of -1.49%. Regarding short-term risk, PIII is less volatile compared to CANO-WT. This indicates lower risk in terms of short-term price fluctuations for PIII.Check CANO-WT's competition here
Aesthetic Medical International Holdings Group Limited (NASDAQ: AIH)
PIII vs AIH Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIII stands at 30.6M. In comparison, AIH has a market cap of 15.9M. Regarding current trading prices, PIII is priced at $8.96 on the NASDAQ, while AIH trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIII currently has a P/E ratio of -0.28, whereas AIH's P/E ratio is -2.78. In terms of profitability, PIII's ROE is +1.61%, compared to AIH's ROE of +1.16%. Regarding short-term risk, PIII is less volatile compared to AIH. This indicates lower risk in terms of short-term price fluctuations for PIII.Check AIH's competition here
Cano Health, Inc. (NYSE: CANO)
PIII vs CANO Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIII stands at 30.6M. In comparison, CANO has a market cap of 12.4M. Regarding current trading prices, PIII is priced at $8.96 on the NASDAQ, while CANO trades at $2.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIII currently has a P/E ratio of -0.28, whereas CANO's P/E ratio is -0.01. In terms of profitability, PIII's ROE is +1.61%, compared to CANO's ROE of -1.49%. Regarding short-term risk, PIII is less volatile compared to CANO. This indicates lower risk in terms of short-term price fluctuations for PIII.Check CANO's competition here
Avem Health Partners, Inc. (NYSE: FPCG)
PIII vs FPCG Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIII stands at 30.6M. In comparison, FPCG has a market cap of 10.1M. Regarding current trading prices, PIII is priced at $8.96 on the NASDAQ, while FPCG trades at $1,025.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIII currently has a P/E ratio of -0.28, whereas FPCG's P/E ratio is 0.09. In terms of profitability, PIII's ROE is +1.61%, compared to FPCG's ROE of +0.00%. Regarding short-term risk, PIII is more volatile compared to FPCG. This indicates higher risk in terms of short-term price fluctuations for PIII.Check FPCG's competition here
Field Trip Health Ltd. (NASDAQ: FTRP)
PIII vs FTRP Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIII stands at 30.6M. In comparison, FTRP has a market cap of 9.8M. Regarding current trading prices, PIII is priced at $8.96 on the NASDAQ, while FTRP trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIII currently has a P/E ratio of -0.28, whereas FTRP's P/E ratio is -1.22. In terms of profitability, PIII's ROE is +1.61%, compared to FTRP's ROE of -0.62%. Regarding short-term risk, PIII is less volatile compared to FTRP. This indicates lower risk in terms of short-term price fluctuations for PIII.Check FTRP's competition here
American Shared Hospital Services (AMEX: AMS)
PIII vs AMS Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIII stands at 30.6M. In comparison, AMS has a market cap of 9.5M. Regarding current trading prices, PIII is priced at $8.96 on the NASDAQ, while AMS trades at $1.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIII currently has a P/E ratio of -0.28, whereas AMS's P/E ratio is -5.66. In terms of profitability, PIII's ROE is +1.61%, compared to AMS's ROE of -0.07%. Regarding short-term risk, PIII is more volatile compared to AMS. This indicates higher risk in terms of short-term price fluctuations for PIII.Check AMS's competition here
Basel Medical Group Ltd Ordinary Shares (NASDAQ: BMGL)
PIII vs BMGL Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIII stands at 30.6M. In comparison, BMGL has a market cap of 7.6M. Regarding current trading prices, PIII is priced at $8.96 on the NASDAQ, while BMGL trades at $4.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIII currently has a P/E ratio of -0.28, whereas BMGL's P/E ratio is -0.91. In terms of profitability, PIII's ROE is +1.61%, compared to BMGL's ROE of -1.74%. Regarding short-term risk, PIII is less volatile compared to BMGL. This indicates lower risk in terms of short-term price fluctuations for PIII.Check BMGL's competition here
20/20 Biolabs Inc. (NASDAQ: AIDX)
PIII vs AIDX Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIII stands at 30.6M. In comparison, AIDX has a market cap of 7.2M. Regarding current trading prices, PIII is priced at $8.96 on the NASDAQ, while AIDX trades at $0.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIII currently has a P/E ratio of -0.28, whereas AIDX's P/E ratio is -1.12. In terms of profitability, PIII's ROE is +1.61%, compared to AIDX's ROE of -3.87%. Regarding short-term risk, PIII is less volatile compared to AIDX. This indicates lower risk in terms of short-term price fluctuations for PIII.Check AIDX's competition here
ModivCare Inc. (NASDAQ: MODV)
PIII vs MODV Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIII stands at 30.6M. In comparison, MODV has a market cap of 6.2M. Regarding current trading prices, PIII is priced at $8.96 on the NASDAQ, while MODV trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIII currently has a P/E ratio of -0.28, whereas MODV's P/E ratio is -0.06. In terms of profitability, PIII's ROE is +1.61%, compared to MODV's ROE of +1.36%. Regarding short-term risk, PIII is more volatile compared to MODV. This indicates higher risk in terms of short-term price fluctuations for PIII.Check MODV's competition here
Greenbrook TMS Inc. (NASDAQ: GBNH)
PIII vs GBNH Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIII stands at 30.6M. In comparison, GBNH has a market cap of 5.5M. Regarding current trading prices, PIII is priced at $8.96 on the NASDAQ, while GBNH trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIII currently has a P/E ratio of -0.28, whereas GBNH's P/E ratio is -0.06. In terms of profitability, PIII's ROE is +1.61%, compared to GBNH's ROE of +15.74%. Regarding short-term risk, PIII is less volatile compared to GBNH. This indicates lower risk in terms of short-term price fluctuations for PIII.Check GBNH's competition here
Starling Oncology Inc. Wt (NASDAQ: STLNW)
PIII vs STLNW Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIII stands at 30.6M. In comparison, STLNW has a market cap of 5.3M. Regarding current trading prices, PIII is priced at $8.96 on the NASDAQ, while STLNW trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIII currently has a P/E ratio of -0.28, whereas STLNW's P/E ratio is N/A. In terms of profitability, PIII's ROE is +1.61%, compared to STLNW's ROE of +2.10%. Regarding short-term risk, PIII is less volatile compared to STLNW. This indicates lower risk in terms of short-term price fluctuations for PIII.Check STLNW's competition here
Regional Health Properties, Inc. (AMEX: RHE-PA)
PIII vs RHE-PA Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIII stands at 30.6M. In comparison, RHE-PA has a market cap of 5.2M. Regarding current trading prices, PIII is priced at $8.96 on the NASDAQ, while RHE-PA trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIII currently has a P/E ratio of -0.28, whereas RHE-PA's P/E ratio is -0.09. In terms of profitability, PIII's ROE is +1.61%, compared to RHE-PA's ROE of +1.09%. Regarding short-term risk, PIII is less volatile compared to RHE-PA. This indicates lower risk in terms of short-term price fluctuations for PIII.Check RHE-PA's competition here
Regional Health Properties, Inc. (AMEX: RHE)
PIII vs RHE Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIII stands at 30.6M. In comparison, RHE has a market cap of 5.2M. Regarding current trading prices, PIII is priced at $8.96 on the NASDAQ, while RHE trades at $2.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIII currently has a P/E ratio of -0.28, whereas RHE's P/E ratio is -1.79. In terms of profitability, PIII's ROE is +1.61%, compared to RHE's ROE of -1.31%. Regarding short-term risk, PIII is less volatile compared to RHE. This indicates lower risk in terms of short-term price fluctuations for PIII.Check RHE's competition here
The Oncology Institute, Inc. (NASDAQ: TOIIW)
PIII vs TOIIW Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIII stands at 30.6M. In comparison, TOIIW has a market cap of 4.7M. Regarding current trading prices, PIII is priced at $8.96 on the NASDAQ, while TOIIW trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIII currently has a P/E ratio of -0.28, whereas TOIIW's P/E ratio is -0.17. In terms of profitability, PIII's ROE is +1.61%, compared to TOIIW's ROE of +2.10%. Regarding short-term risk, PIII is more volatile compared to TOIIW. This indicates higher risk in terms of short-term price fluctuations for PIII.Check TOIIW's competition here
IMAC Holdings, Inc. (NASDAQ: IMACW)
PIII vs IMACW Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIII stands at 30.6M. In comparison, IMACW has a market cap of 1.7M. Regarding current trading prices, PIII is priced at $8.96 on the NASDAQ, while IMACW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIII currently has a P/E ratio of -0.28, whereas IMACW's P/E ratio is N/A. In terms of profitability, PIII's ROE is +1.61%, compared to IMACW's ROE of +0.73%. Regarding short-term risk, PIII is less volatile compared to IMACW. This indicates lower risk in terms of short-term price fluctuations for PIII.Check IMACW's competition here
Endovia Health Sciences, Inc. (AMEX: EDVA)
PIII vs EDVA Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIII stands at 30.6M. In comparison, EDVA has a market cap of 1.7M. Regarding current trading prices, PIII is priced at $8.96 on the NASDAQ, while EDVA trades at $0.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIII currently has a P/E ratio of -0.28, whereas EDVA's P/E ratio is N/A. In terms of profitability, PIII's ROE is +1.61%, compared to EDVA's ROE of N/A. Regarding short-term risk, PIII is less volatile compared to EDVA. This indicates lower risk in terms of short-term price fluctuations for PIII.Check EDVA's competition here
EUDA Health Holdings Limited (NASDAQ: EUDAW)
PIII vs EUDAW Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIII stands at 30.6M. In comparison, EUDAW has a market cap of 1.1M. Regarding current trading prices, PIII is priced at $8.96 on the NASDAQ, while EUDAW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIII currently has a P/E ratio of -0.28, whereas EUDAW's P/E ratio is 0.04. In terms of profitability, PIII's ROE is +1.61%, compared to EUDAW's ROE of +1.20%. Regarding short-term risk, PIII is less volatile compared to EUDAW. This indicates lower risk in terms of short-term price fluctuations for PIII.Check EUDAW's competition here
Concord Medical Services Holdings Limited (NYSE: CCM)
PIII vs CCM Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIII stands at 30.6M. In comparison, CCM has a market cap of 681.5K. Regarding current trading prices, PIII is priced at $8.96 on the NASDAQ, while CCM trades at $4.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIII currently has a P/E ratio of -0.28, whereas CCM's P/E ratio is -0.31. In terms of profitability, PIII's ROE is +1.61%, compared to CCM's ROE of +0.06%. Regarding short-term risk, PIII is less volatile compared to CCM. This indicates lower risk in terms of short-term price fluctuations for PIII.Check CCM's competition here
NewGenIvf Group Limited (NASDAQ: NIVF)
PIII vs NIVF Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIII stands at 30.6M. In comparison, NIVF has a market cap of 72K. Regarding current trading prices, PIII is priced at $8.96 on the NASDAQ, while NIVF trades at $1.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIII currently has a P/E ratio of -0.28, whereas NIVF's P/E ratio is 0.56. In terms of profitability, PIII's ROE is +1.61%, compared to NIVF's ROE of +0.33%. Regarding short-term risk, PIII is less volatile compared to NIVF. This indicates lower risk in terms of short-term price fluctuations for PIII.Check NIVF's competition here
NewGenIvf Group Limited (NASDAQ: NIVFW)
PIII vs NIVFW Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIII stands at 30.6M. In comparison, NIVFW has a market cap of 45.7K. Regarding current trading prices, PIII is priced at $8.96 on the NASDAQ, while NIVFW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIII currently has a P/E ratio of -0.28, whereas NIVFW's P/E ratio is -0.01. In terms of profitability, PIII's ROE is +1.61%, compared to NIVFW's ROE of +0.33%. Regarding short-term risk, PIII is more volatile compared to NIVFW. This indicates higher risk in terms of short-term price fluctuations for PIII.Check NIVFW's competition here
Mobile-health Network Solutions Class A Ordinary Shares (NASDAQ: MNDR)
PIII vs MNDR Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIII stands at 30.6M. In comparison, MNDR has a market cap of 34.9K. Regarding current trading prices, PIII is priced at $8.96 on the NASDAQ, while MNDR trades at $1.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIII currently has a P/E ratio of -0.28, whereas MNDR's P/E ratio is -0.04. In terms of profitability, PIII's ROE is +1.61%, compared to MNDR's ROE of -0.46%. Regarding short-term risk, PIII is less volatile compared to MNDR. This indicates lower risk in terms of short-term price fluctuations for PIII.Check MNDR's competition here
Talkspace, Inc. (NASDAQ: TALKW)
PIII vs TALKW Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIII stands at 30.6M. In comparison, TALKW has a market cap of 33.5K. Regarding current trading prices, PIII is priced at $8.96 on the NASDAQ, while TALKW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIII currently has a P/E ratio of -0.28, whereas TALKW's P/E ratio is 0.00. In terms of profitability, PIII's ROE is +1.61%, compared to TALKW's ROE of +0.00%. Regarding short-term risk, PIII is less volatile compared to TALKW. This indicates lower risk in terms of short-term price fluctuations for PIII.Check TALKW's competition here
Skylight Health Group Inc. (NASDAQ: SLHG)
PIII vs SLHG Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIII stands at 30.6M. In comparison, SLHG has a market cap of 0. Regarding current trading prices, PIII is priced at $8.96 on the NASDAQ, while SLHG trades at $0.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIII currently has a P/E ratio of -0.28, whereas SLHG's P/E ratio is -1.48. In terms of profitability, PIII's ROE is +1.61%, compared to SLHG's ROE of N/A. Regarding short-term risk, PIII is less volatile compared to SLHG. This indicates lower risk in terms of short-term price fluctuations for PIII.Check SLHG's competition here
Skylight Health Group Inc. (NASDAQ: SLHGP)
PIII vs SLHGP Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIII stands at 30.6M. In comparison, SLHGP has a market cap of 0. Regarding current trading prices, PIII is priced at $8.96 on the NASDAQ, while SLHGP trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIII currently has a P/E ratio of -0.28, whereas SLHGP's P/E ratio is -30.38. In terms of profitability, PIII's ROE is +1.61%, compared to SLHGP's ROE of -0.48%. Regarding short-term risk, PIII is more volatile compared to SLHGP. This indicates higher risk in terms of short-term price fluctuations for PIII.Check SLHGP's competition here
Almost Family Inc. (NASDAQ: AFAM)
PIII vs AFAM Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIII stands at 30.6M. In comparison, AFAM has a market cap of 0. Regarding current trading prices, PIII is priced at $8.96 on the NASDAQ, while AFAM trades at $56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIII currently has a P/E ratio of -0.28, whereas AFAM's P/E ratio is N/A. In terms of profitability, PIII's ROE is +1.61%, compared to AFAM's ROE of +0.06%. Regarding short-term risk, PIII is less volatile compared to AFAM. This indicates lower risk in terms of short-term price fluctuations for PIII.Check AFAM's competition here
SOC Telemed, Inc. (NASDAQ: TLMD)
PIII vs TLMD Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIII stands at 30.6M. In comparison, TLMD has a market cap of 0. Regarding current trading prices, PIII is priced at $8.96 on the NASDAQ, while TLMD trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIII currently has a P/E ratio of -0.28, whereas TLMD's P/E ratio is -1.60. In terms of profitability, PIII's ROE is +1.61%, compared to TLMD's ROE of -0.46%. Regarding short-term risk, PIII is more volatile compared to TLMD. This indicates higher risk in terms of short-term price fluctuations for PIII.Check TLMD's competition here
Hanger, Inc. (NYSE: HNGR)
PIII vs HNGR Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIII stands at 30.6M. In comparison, HNGR has a market cap of 0. Regarding current trading prices, PIII is priced at $8.96 on the NASDAQ, while HNGR trades at $18.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIII currently has a P/E ratio of -0.28, whereas HNGR's P/E ratio is 19.71. In terms of profitability, PIII's ROE is +1.61%, compared to HNGR's ROE of +0.52%. Regarding short-term risk, PIII is more volatile compared to HNGR. This indicates higher risk in terms of short-term price fluctuations for PIII.Check HNGR's competition here
New Frontier Health Corporation (NYSE: NFH)
PIII vs NFH Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIII stands at 30.6M. In comparison, NFH has a market cap of 0. Regarding current trading prices, PIII is priced at $8.96 on the NASDAQ, while NFH trades at $11.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIII currently has a P/E ratio of -0.28, whereas NFH's P/E ratio is -19.75. In terms of profitability, PIII's ROE is +1.61%, compared to NFH's ROE of -0.06%. Regarding short-term risk, PIII is more volatile compared to NFH. This indicates higher risk in terms of short-term price fluctuations for PIII.Check NFH's competition here
Diversicare Healthcare Services, Inc. (NASDAQ: DVCR)
PIII vs DVCR Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIII stands at 30.6M. In comparison, DVCR has a market cap of 0. Regarding current trading prices, PIII is priced at $8.96 on the NASDAQ, while DVCR trades at $10.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIII currently has a P/E ratio of -0.28, whereas DVCR's P/E ratio is 28.34. In terms of profitability, PIII's ROE is +1.61%, compared to DVCR's ROE of -0.15%. Regarding short-term risk, PIII is more volatile compared to DVCR. This indicates higher risk in terms of short-term price fluctuations for PIII.Check DVCR's competition here
ATI Physical Therapy, Inc. (NYSE: ATIP-WT)
PIII vs ATIP-WT Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIII stands at 30.6M. In comparison, ATIP-WT has a market cap of 0. Regarding current trading prices, PIII is priced at $8.96 on the NASDAQ, while ATIP-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIII currently has a P/E ratio of -0.28, whereas ATIP-WT's P/E ratio is N/A. In terms of profitability, PIII's ROE is +1.61%, compared to ATIP-WT's ROE of +2.05%. Regarding short-term risk, PIII is less volatile compared to ATIP-WT. This indicates lower risk in terms of short-term price fluctuations for PIII.Check ATIP-WT's competition here
SOC Telemed, Inc. (NASDAQ: TLMDW)
PIII vs TLMDW Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIII stands at 30.6M. In comparison, TLMDW has a market cap of 0. Regarding current trading prices, PIII is priced at $8.96 on the NASDAQ, while TLMDW trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIII currently has a P/E ratio of -0.28, whereas TLMDW's P/E ratio is N/A. In terms of profitability, PIII's ROE is +1.61%, compared to TLMDW's ROE of -0.46%. Regarding short-term risk, PIII is less volatile compared to TLMDW. This indicates lower risk in terms of short-term price fluctuations for PIII.Check TLMDW's competition here
Tivity Health, Inc. (NASDAQ: TVTY)
PIII vs TVTY Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIII stands at 30.6M. In comparison, TVTY has a market cap of 0. Regarding current trading prices, PIII is priced at $8.96 on the NASDAQ, while TVTY trades at $32.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIII currently has a P/E ratio of -0.28, whereas TVTY's P/E ratio is 19.06. In terms of profitability, PIII's ROE is +1.61%, compared to TVTY's ROE of +1.75%. Regarding short-term risk, PIII is more volatile compared to TVTY. This indicates higher risk in terms of short-term price fluctuations for PIII.Check TVTY's competition here
DocGo Inc. (NASDAQ: DCGOW)
PIII vs DCGOW Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIII stands at 30.6M. In comparison, DCGOW has a market cap of 0. Regarding current trading prices, PIII is priced at $8.96 on the NASDAQ, while DCGOW trades at $1.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIII currently has a P/E ratio of -0.28, whereas DCGOW's P/E ratio is N/A. In terms of profitability, PIII's ROE is +1.61%, compared to DCGOW's ROE of -1.16%. Regarding short-term risk, PIII is less volatile compared to DCGOW. This indicates lower risk in terms of short-term price fluctuations for PIII.Check DCGOW's competition here
Kindred Healthcare, Inc. (NYSE: KND)
PIII vs KND Comparison September 2026
P3 Health Partners Inc. (NASDAQ: PIII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIII stands at 30.6M. In comparison, KND has a market cap of 0. Regarding current trading prices, PIII is priced at $8.96 on the NASDAQ, while KND trades at $9.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIII currently has a P/E ratio of -0.28, whereas KND's P/E ratio is -1.14. In terms of profitability, PIII's ROE is +1.61%, compared to KND's ROE of -0.53%. Regarding short-term risk, PIII is more volatile compared to KND. This indicates higher risk in terms of short-term price fluctuations for PIII.Check KND's competition here